AzTrials
AzTrials

Bronchopulmonary DysplasiaPhase 1NCT00840983

Effects of Delayed Cord Clamping in Very Low Birth Weight Infants

A Phase 1 study testing delayed cord clamping in people with Bronchopulmonary Dysplasia and Necrotizing Enterocolitis, run by University of Rhode Island at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to see if a brief delay in cord clamping for 30 to 45 seconds would result in higher hematocrit levels, fewer transfusions, healthier lungs, and better motor function at 40 wks and 7 months of age. Read more about this study

Who is it for?
Any age, women only
What is being tested?
delayed cord clamping
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteUnited States
Study dates
Aug 2003to Dec 2006
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Women pregnant with gestation 24 to 31.6 weeks of singleton pregnancy by obstetrical evaluation
  • Obstetrician's approval of enrollment into study
  • Parental consent
  • Any mode of birth will be included

Who cannot join

  • Obstetrician's refusal to enroll infants
  • Parental refusal for consent
  • Prenatally-diagnosed major congenital anomalies [or multiple gestations]
  • Intent to withhold or withdraw care
  • Severe or multiple maternal illnesses, frank vaginal bleeding, placenta abruption or previa
  • Mothers who are institutionalized or psychotic

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Women & Infants Hospital

    Providence, Rhode Island, 02905

Other trials in United States

About this study

Official title: Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants

The purpose of this study was to see if a brief delay in cord clamping for 30 to 45 seconds would result in higher hematocrit levels, fewer transfusions, healthier lungs, and better motor function at 40 wks and 7 months of age.

Read the detailed description

When cord clamping is delayed at birth or the cord is milked, infants receive a placental transfusion of 10-15 mL/kg during the first few minutes of life. This additional blood improves hemodynamic stability and may reduce the risk of intraventricular hemorrhage (IVH) and the vulnerability of infants to inflammatory processes. This blood also contains stem cells that are important in repairing tissue and building immunocompetence.

The current randomized controlled trial prospectively tested the effects of DCC for 30-45 seconds followed by 1 cord milking with the aim of confirming our prior work and providing long-term follow-up. Our a priori hypotheses were that DCC would reduce the incidence of IVH, LOS, and result in better motor function at 18-22 months.

Being tested
delayed cord clamping
Keywords
delayed cord clamping, very low birthweight infant, bronchopulmonary dysplasia, intraventricular hemorrhage, motor function
Medical subject headings
Bronchopulmonary Dysplasia, Enterocolitis, Necrotizing, Neonatal Sepsis, Motor Skills Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • delayed cord clampingProcedure or surgery

    Also called cord clamping time

    cord clamping was delayed for 30 to 45 seconds and infant was held lower than the level of the placenta

Study groups in NCT00840983
Study groupRoleWhat they receive
1-Immediate Cord ClampingNo interventioninfants received the routine care of immediate clamping of the umbilical cord
2-Delayed Cord ClampingExperimentalafter birth, cord clamping was delayed 30 to 45 seconds while infant was held lower than the level of the placenta.
Receives: Procedure: delayed cord clamping

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. VLBW infants in the delayed clamped group will have less chronic lung disease at 36 weeks postmenstrual age compared to VLBW infants in the immediate cord clamped grouped

    Measured: 36 wks postmenstrual age

  2. VLBW infants in the delayed clamped group will have fewer incidences of suspected necrotizing enterocolitis during the NICU stay when compared with VLBW infants in the immediate cord clamped group

    Measured: Hospital discharge

  3. VLBW infants in the delayed clamped group will have better motor function by 6 to corrected age when compared with VLBW infants in the immediate cord clamped group

    Measured: 7 months corrected age

Secondary outcomes (2)
  1. Infants in the delayed cord clamping group will have less IVH than infants in the immediate clamping group

    Measured: NICU stay

  2. Infants in the delayed clamping group will hvae less late onset sepsis than infants in the immediate clamping group.

    Measured: NICU Stay

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2009 (estimated)
  2. Study startAug 2003
  3. Primary completionNov 2005
  4. Study completionDec 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00840983
Sponsor's protocol ID
Mercer-K23-03
Other IDs
R01NR010015-01A2
Status last verified
Nov 2015
First submitted
10 Feb 2009
Last updated
30 Nov 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Mercer JS, Vohr BR, McGrath MM, Padbury JF, Wallach M, Oh W. Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics. 2006 Apr;117(4):1235-42. doi: 10.1542/peds.2005-1706.

    PubMed 16585320
  • Mercer JS, Vohr BR, Erickson-Owens DA, Padbury JF, Oh W. Seven-month developmental outcomes of very low birth weight infants enrolled in a randomized controlled trial of delayed versus immediate cord clamping. J Perinatol. 2010 Jan;30(1):11-6. doi: 10.1038/jp.2009.170. Epub 2009 Oct 22.

    PubMed 19847185
  • Mercer JS, Erickson-Owens DA, Vohr BR, Tucker RJ, Parker AB, Oh W, Padbury JF. Effects of Placental Transfusion on Neonatal and 18 Month Outcomes in Preterm Infants: A Randomized Controlled Trial. J Pediatr. 2016 Jan;168:50-55.e1. doi: 10.1016/j.jpeds.2015.09.068. Epub 2015 Nov 4.

    PubMed 26547399

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing delayed cord clamping in people with Bronchopulmonary Dysplasia and Necrotizing Enterocolitis, run by University of Rhode Island at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Nov 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

VLBW infants in the delayed clamped group will have less chronic lung disease at 36 weeks postmenstrual age compared to VLBW infants in the immediate cord clamped grouped (time frame: 36 wks postmenstrual age). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00840983, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2015; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in